{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T16:41:00Z","timestamp":1780072860365,"version":"3.54.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T00:00:00Z","timestamp":1719446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T00:00:00Z","timestamp":1719446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s11030-024-10913-w","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T14:14:08Z","timestamp":1719497648000},"page":"1323-1335","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Study of multifunctional anti-AD ligands: design, synthesis, X-ray crystal structure and biological evaluation of diosmetin derivatives"],"prefix":"10.1007","volume":"29","author":[{"given":"Aihong","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyue","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanzhen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodi","family":"Kou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,27]]},"reference":[{"issue":"7","key":"10913_CR1","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S1474-4422(10)70119-8","volume":"9","author":"F Mangialasche","year":"2010","unstructured":"Mangialasche F, Solomon A, Winblad B, Mecocci P, Kivipelto M (2010) Alzheimer\u2019s disease: clinical trials and drug development. Lancet Neurol 9(7):702\u2013716. https:\/\/doi.org\/10.1016\/S1474-4422(10)70119-8","journal-title":"Lancet Neurol"},{"issue":"10284","key":"10913_CR2","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P, De Strooper B, Kivipelto M, Holstege H, Ch\u00e9telat G, Teunissen CE, Cummings J, van der Flier WM (2021) Alzheimer\u2019s disease. Lancet 397(10284):1577\u20131590. https:\/\/doi.org\/10.1016\/S0140-6736(20)32205-4","journal-title":"Lancet"},{"issue":"12","key":"10913_CR3","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1111\/cns.13058","volume":"24","author":"SY Lee","year":"2018","unstructured":"Lee SY, Chiu YJ, Yang SM, Chen CM, Huang CC, Lee-Chen GJ, Lin WW, Chang KH (2018) Novel synthetic chalcone-coumarin hybrid for A beta aggregation reduction, antioxidation, and neuroprotection. CNS Neurosci Ther 24(12):1286\u20131298. https:\/\/doi.org\/10.1111\/cns.13058","journal-title":"CNS Neurosci Ther"},{"issue":"5","key":"10913_CR4","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.freeradbiomed.2010.11.026","volume":"51","author":"M Dumont","year":"2011","unstructured":"Dumont M, Beal MF (2011) Neuroprotective strategies involving ROS in Alzheimer disease. Free Radic Biol Med 51(5):1014\u20131026. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2010.11.026","journal-title":"Free Radic Biol Med"},{"issue":"2\u20133","key":"10913_CR5","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.tox.2011.03.001","volume":"283","author":"K Jomova","year":"2011","unstructured":"Jomova K, Valko M (2011) Advances in metal-induced oxidative stress and human disease. Toxicology 283(2\u20133):65\u201387. https:\/\/doi.org\/10.1016\/j.tox.2011.03.001","journal-title":"Toxicology"},{"key":"10913_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114806","volume":"244","author":"Y Wang","year":"2022","unstructured":"Wang Y, Xiong B, Lin H, Li Q, Yang H, Qiao Y, Li Q, Xu Z, Lyu W, Qu W, Liu W, Chen Y, Feng F, Sun H (2022) Design, synthesis and evaluation of fused hybrids with acetylcholinesterase inhibiting and Nrf2 activating functions for Alzheimer\u2019s disease. Eur J Med Chem 244:114806. https:\/\/doi.org\/10.1016\/j.ejmech.2022.114806","journal-title":"Eur J Med Chem"},{"key":"10913_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114729","volume":"243","author":"X Lu","year":"2022","unstructured":"Lu X, Qin N, Liu Y, Du C, Feng F, Liu W, Chen Y, Sun H (2022) Design, synthesis, and biological evaluation of aromatic tertiary amine derivatives as selective butyrylcholinesterase inhibitors for the treatment of Alzheimer\u2019s disease. Eur J Med Chem 243:114729. https:\/\/doi.org\/10.1016\/j.ejmech.2022.114729","journal-title":"Eur J Med Chem"},{"issue":"1","key":"10913_CR8","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3390\/biom10010040","volume":"10","author":"GD Stanciu","year":"2019","unstructured":"Stanciu GD, Luca A, Rusu RN, Bild V, Beschea Chiriac SI, Solcan C, Bild W, Ababei DC (2019) Alzheimer\u2019s disease pharmacotherapy in relation to cholinergic system involvement. Biomolecules 10(1):4. https:\/\/doi.org\/10.3390\/biom10010040","journal-title":"Biomolecules"},{"issue":"3","key":"10913_CR9","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.3233\/JAD-160733","volume":"55","author":"DE Moss","year":"2016","unstructured":"Moss DE, Perez RG, Kobayashi H, Darreh-Shori T (2016) Cholinesterase inhibitor therapy in Alzheimer\u2019s disease: the limits and tolerability of irreversible cns-selective acetylcholinesterase inhibition in primates. J Alzheimers Dis 55(3):1285\u20131294. https:\/\/doi.org\/10.3233\/JAD-160733","journal-title":"J Alzheimers Dis"},{"issue":"S1","key":"10913_CR10","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1017\/s1041610203008676","volume":"14","author":"NH Greig","year":"2005","unstructured":"Greig NH, Lahiri DK, Sambamurti K (2005) Butyrylcholinesterase: an important new target in Alzheimer\u2019s disease therapy. Int Psychogeriatr 14(S1):77\u201391. https:\/\/doi.org\/10.1017\/s1041610203008676","journal-title":"Int Psychogeriatr"},{"issue":"2","key":"10913_CR11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.abb.2009.12.005","volume":"494","author":"P Masson","year":"2010","unstructured":"Masson P, Lockridge O (2010) Butyrylcholinesterase for protection from organophosphorus poisons: catalytic complexities and hysteretic behavior. Arch Biochem Biophys 494(2):107\u2013120. https:\/\/doi.org\/10.1016\/j.abb.2009.12.005","journal-title":"Arch Biochem Biophys"},{"issue":"8","key":"10913_CR12","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.bbalip.2010.02.005","volume":"1801","author":"DA Butterfield","year":"2010","unstructured":"Butterfield DA, Bader Lange ML, Sultana R (2010) Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer\u2019s disease. Biochim Biophys Acta 1801(8):924\u2013929. https:\/\/doi.org\/10.1016\/j.bbalip.2010.02.005","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"10913_CR13","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1515\/revneuro-2017-0063","volume":"29","author":"AB Reiss","year":"2018","unstructured":"Reiss AB, Arain HA, Stecker MM, Siegart NM, Kasselman LJ (2018) Amyloid toxicity in Alzheimer\u2019s disease. Rev Neurosci 29(6):613\u2013627. https:\/\/doi.org\/10.1515\/revneuro-2017-0063","journal-title":"Rev Neurosci"},{"issue":"1","key":"10913_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/molpharm.123.000726","volume":"105","author":"M Markovi","year":"2024","unstructured":"Markovi M, Milosevic J, Wang WR, Cao YG (2024) Passive immunotherapies targeting amyloid-\u03b2 in Alzheimer\u2019s disease: a quantitative systems pharmacology perspective. Mol Pharmacol 105(1):1\u201313. https:\/\/doi.org\/10.1124\/molpharm.123.000726","journal-title":"Mol Pharmacol"},{"issue":"5","key":"10913_CR15","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.neuint.2012.08.014","volume":"62","author":"MA Greenough","year":"2013","unstructured":"Greenough MA, Camakaris J, Bush AI (2013) Metal dyshomeostasis and oxidative stress in Alzheimer\u2019s disease. Neurochem Int 62(5):540\u2013555. https:\/\/doi.org\/10.1016\/j.neuint.2012.08.014","journal-title":"Neurochem Int"},{"key":"10913_CR16","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.redox.2017.10.014","volume":"14","author":"C Cheignon","year":"2018","unstructured":"Cheignon C, Tomas M, Bonnefont-Rousselot D, Faller P, Hureau C, Collin F (2018) Oxidative stress and the amyloid beta peptide in Alzheimer\u2019s disease. Redox Biol 14:450\u2013464. https:\/\/doi.org\/10.1016\/j.redox.2017.10.014","journal-title":"Redox Biol"},{"issue":"9","key":"10913_CR17","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1089\/ars.2016.6848","volume":"27","author":"L Diomede","year":"2017","unstructured":"Diomede L, Romeo M, Rognoni P, Beeg M, Foray C, Ghibaudi E, Palladini G, Cherny RA, Verga L, Capello GL, Perfetti V, Fiordaliso F, Merlini G, Salmona M (2017) Cardiac light chain amyloidosis: the role of metal ions in oxidative stress and mitochondrial damage. Antioxid Redox Signal 27(9):567\u2013582. https:\/\/doi.org\/10.1089\/ars.2016.6848","journal-title":"Antioxid Redox Signal"},{"key":"10913_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114216","volume":"233","author":"A Yang","year":"2022","unstructured":"Yang A, Liu C, Zhang H, Wu J, Shen R, Kou X (2022) A multifunctional anti-AD approach: design, synthesis, X-ray crystal structure, biological evaluation and molecular docking of chrysin derivatives. Eur J Med Chem 233:114216. https:\/\/doi.org\/10.1016\/j.ejmech.2022.114216","journal-title":"Eur J Med Chem"},{"key":"10913_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2019.111958","volume":"187","author":"Z Sang","year":"2020","unstructured":"Sang Z, Wang K, Shi J, Cheng X, Zhu G, Wei R, Ma Q, Yu L, Zhao Y, Tan Z, Liu W (2020) Apigenin-rivastigmine hybrids as multi-target-directed liagnds for the treatment of Alzheimer\u2019s disease. Eur J Med Chem 187:111958. https:\/\/doi.org\/10.1016\/j.ejmech.2019.111958","journal-title":"Eur J Med Chem"},{"issue":"5","key":"10913_CR20","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1002\/med.21699","volume":"41","author":"C Albertini","year":"2020","unstructured":"Albertini C, Salerno A, Sena Murteira Pinheiro P, Bolognesi ML (2020) From combinations to multitarget-directed ligands: A continuum in Alzheimer\u2019s disease polypharmacology. Med Res Rev 41(5):2606\u20132633. https:\/\/doi.org\/10.1002\/med.21699","journal-title":"Med Res Rev"},{"key":"10913_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114689","volume":"242","author":"W Liu","year":"2022","unstructured":"Liu W, Wu L, Liu W, Tian L, Chen H, Wu Z, Wang N, Liu X, Qiu J, Feng X, Xu Z, Jiang X, Zhao Q (2022) Design, synthesis and biological evaluation of novel coumarin derivatives as multifunctional ligands for the treatment of Alzheimer\u2019s disease. Eur J Med Chem 242:114689. https:\/\/doi.org\/10.1016\/j.ejmech.2022.114689","journal-title":"Eur J Med Chem"},{"key":"10913_CR22","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1007\/s00044-017-2078-4","volume":"27","author":"M Singh","year":"2018","unstructured":"Singh M, Kaur M, Vyas B, Silakari O (2018) Design, synthesis and biological evaluation of 2-Phenyl-4H-chromen-4-one derivatives as polyfunctional compounds against Alzheimer\u2019s disease. Med Chem Res 27:520\u2013530. https:\/\/doi.org\/10.1007\/s00044-017-2078-4","journal-title":"Med Chem Res"},{"issue":"2","key":"10913_CR23","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1021\/cn400213r","volume":"5","author":"FI Baptista","year":"2014","unstructured":"Baptista FI, Henriques AG, Silva AM, Wiltfang J, da Cruz e Silva OA (2014) Flavonoids as therapeutic compounds targeting key proteins involved in Alzheimer\u2019s disease. ACS Chem Neurosci 5(2):83\u201392. https:\/\/doi.org\/10.1021\/cn400213r","journal-title":"ACS Chem Neurosci"},{"key":"10913_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2021.105976","volume":"166","author":"C Liu","year":"2021","unstructured":"Liu C, Kou X, Wang X, Wu J, Yang A, Shen R (2021) Novel chrysin derivatives as hidden multifunctional agents for anti-Alzheimer\u2019s disease: design, synthesis and in vitro evaluation. Eur J Pharm Sci 166:105976. https:\/\/doi.org\/10.1016\/j.ejps.2021.105976","journal-title":"Eur J Pharm Sci"},{"key":"10913_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2021.128316","volume":"49","author":"J Wu","year":"2021","unstructured":"Wu J, Kou X, Ju H, Zhang H, Yang A, Shen R (2021) Design, synthesis and biological evaluation of naringenin carbamate derivatives as potential multifunctional agents for the treatment of Alzheimer\u2019s disease. Bioorg Med Chem Lett 49:128316. https:\/\/doi.org\/10.1016\/j.bmcl.2021.128316","journal-title":"Bioorg Med Chem Lett"},{"issue":"10","key":"10913_CR26","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1007\/s11655-013-1595-3","volume":"19","author":"K Patel","year":"2013","unstructured":"Patel K, Gadewar M, Tahilyani V, Patel DK (2013) A review on pharmacological and analytical aspects of diosmetin: a concise report. Chin J Integr Med 19(10):792\u2013800. https:\/\/doi.org\/10.1007\/s11655-013-1595-3","journal-title":"Chin J Integr Med"},{"key":"10913_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2021.105225","volume":"115","author":"O Ozten","year":"2021","unstructured":"Ozten O, Zengin Kurt B, Sonmez F, Dogan B, Durdagi S (2021) Synthesis, molecular docking and molecular dynamics studies of novel tacrine-carbamate derivatives as potent cholinesterase inhibitors. Bioorg Chem 115:105225. https:\/\/doi.org\/10.1016\/j.bioorg.2021.105225","journal-title":"Bioorg Chem"},{"issue":"5","key":"10913_CR28","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1111\/cbdd.14318","volume":"102","author":"P Sharma","year":"2023","unstructured":"Sharma P, Singh V, Singh M (2023) N-methylpiperazinyl and piperdinylalkyl-O-chalcone derivatives as potential polyfunctional agents against Alzheimer\u2019s disease: design, synthesis and biological evaluation. Chem Biol Drug Des 102(5):1155\u20131175. https:\/\/doi.org\/10.1111\/cbdd.14318","journal-title":"Chem Biol Drug Des"},{"issue":"1","key":"10913_CR29","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1021\/jf0305231","volume":"52","author":"A D\u00e1valos","year":"2004","unstructured":"D\u00e1valos A, G\u00f3mez-Cordov\u00e9sBartolome CB (2004) Extending applicability of the oxygen radical absorbance capacity (ORAC\u2212fluorescein) assay. J Agric Food Chem 52(1):48\u201354. https:\/\/doi.org\/10.1021\/jf0305231","journal-title":"J Agric Food Chem"},{"key":"10913_CR30","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.ejmech.2015.02.063","volume":"94","author":"ZP Sang","year":"2015","unstructured":"Sang ZP, Qiang XM, Li Y, Yuan W, Liu Q, Shi YK, Ang W, Luo YF, Tan ZH, Deng Y (2015) Design, synthesis and evaluation of scutellarein-O-alkylamines as multifunctional agents for the treatment of Alzheimer\u2019s disease. Eur J Med Chem 94:348\u2013366. https:\/\/doi.org\/10.1016\/j.ejmech.2015.02.063","journal-title":"Eur J Med Chem"},{"issue":"42","key":"10913_CR31","doi-asserted-by":"publisher","first-page":"28176","DOI":"10.1074\/jbc.M803159200","volume":"283","author":"A Jan","year":"2008","unstructured":"Jan A, Gokce O, Luthi-Carter R, Lashuel HA (2008) The ratio of monomeric to aggregated forms of Abeta40 and Abeta42 is an important determinant of amyloid-beta aggregation, fibrillogenesis, and toxicity. J Biol Chem 283(42):28176\u201328189. https:\/\/doi.org\/10.1074\/jbc.M803159200","journal-title":"J Biol Chem"},{"issue":"5","key":"10913_CR32","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1111\/j.1471-4159.2006.04426.x","volume":"101","author":"DM Walsh","year":"2007","unstructured":"Walsh DM, Selkoe DJ (2007) A beta oligomers - a decade of discovery. J Neurochem 101(5):1172\u20131184. https:\/\/doi.org\/10.1111\/j.1471-4159.2006.04426.x","journal-title":"J Neurochem"},{"issue":"1","key":"10913_CR33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2174\/1567205052772768","volume":"2","author":"Y Wu","year":"2005","unstructured":"Wu Y, Luo Y (2005) Transgenic C. elegans as a model in Alzheimer\u2019s research. Curr Alzheimer Res 2(1):37\u201345. https:\/\/doi.org\/10.2174\/1567205052772768","journal-title":"Curr Alzheimer Res"},{"key":"10913_CR34","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","volume":"7","author":"GL Ellman","year":"1961","unstructured":"Ellman GL, Courtney KD, Andres V, Featherstone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochemical Pharmacolog 7:88\u201395. https:\/\/doi.org\/10.1016\/0006-2952(61)90145-9","journal-title":"Biochemical Pharmacolog"},{"key":"10913_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2022.133747","volume":"1268","author":"A Yang","year":"2022","unstructured":"Yang A, Zhang H, Hu C, Wang X, Shen R, Kou X, Wang H (2022) Novel coumarin derivatives as multifunctional anti-AD agents: design, synthesis, X-ray crystal structure and biological evaluation. J Mol Struct 1268:133747. https:\/\/doi.org\/10.1016\/j.molstruc.2022.133747","journal-title":"J Mol Struct"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-024-10913-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-024-10913-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-024-10913-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T12:39:25Z","timestamp":1741955965000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-024-10913-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,27]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["10913"],"URL":"https:\/\/doi.org\/10.1007\/s11030-024-10913-w","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,27]]},"assertion":[{"value":"29 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}